These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10794682)

  • 1. N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration.
    Talley JJ; Bertenshaw SR; Brown DL; Carter JS; Graneto MJ; Kellogg MS; Koboldt CM; Yuan J; Zhang YY; Seibert K
    J Med Chem; 2000 May; 43(9):1661-3. PubMed ID: 10794682
    [No Abstract]   [Full Text] [Related]  

  • 2. 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2.
    Talley JJ; Brown DL; Carter JS; Graneto MJ; Koboldt CM; Masferrer JL; Perkins WE; Rogers RS; Shaffer AF; Zhang YY; Zweifel BS; Seibert K
    J Med Chem; 2000 Mar; 43(5):775-7. PubMed ID: 10715145
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor.
    Padi SS; Jain NK; Singh S; Kulkarni SK
    Eur J Pharmacol; 2004 Apr; 491(1):69-76. PubMed ID: 15102535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of colorectal cancer: tumor progression, chemoprevention, and COX-2 inhibition.
    Bresalier RS
    Gastroenterology; 2000 Jul; 119(1):267-8. PubMed ID: 10889181
    [No Abstract]   [Full Text] [Related]  

  • 5. Discovery of a new class of selective cyclooxygenase-2 (COX-2) inhibitor that covalently modifies the isozyme.
    Kalgutkar AS; Crews BC; Rowlinson SW; Garner C; Marnett LJ
    Adv Exp Med Biol; 1999; 469():139-43. PubMed ID: 10667322
    [No Abstract]   [Full Text] [Related]  

  • 6. Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty.
    Malan TP; Marsh G; Hakki SI; Grossman E; Traylor L; Hubbard RC
    Anesthesiology; 2003 Apr; 98(4):950-6. PubMed ID: 12657858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitigation of arthritis by high-dose administration of a COX-2 inhibitor in the collagen-induced arthritis model in the mouse.
    Obukowicz MG; Ornberg RL
    Adv Exp Med Biol; 1999; 469():145-50. PubMed ID: 10667323
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of COX-2 inhibition on the formation and healing of gastric ulcers induced by indomethacin in the rat.
    Godessart N; Salcedo C; Fernández AG; Palacios JM
    Adv Exp Med Biol; 1999; 469():157-63. PubMed ID: 10667325
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cyclooxygenase-2 inhibitors: current concepts (lecture)].
    Nasonov EL
    Ter Arkh; 1999; 71(11):54-7. PubMed ID: 10626339
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
    Gerstenfeld LC; Thiede M; Seibert K; Mielke C; Phippard D; Svagr B; Cullinane D; Einhorn TA
    J Orthop Res; 2003 Jul; 21(4):670-5. PubMed ID: 12798067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
    Aspenberg P
    J Orthop Res; 2004 May; 22(3):684; author reply 685. PubMed ID: 15099653
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal.
    Di Nunno L; Vitale P; Scilimati A; Tacconelli S; Patrignani P
    J Med Chem; 2004 Sep; 47(20):4881-90. PubMed ID: 15369392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The analgesic efficacy of intramuscular parecoxib sodium in postoperative dental pain.
    Mehlisch DR; Desjardins PJ; Daniels S; Hubbard RC
    J Am Dent Assoc; 2004 Nov; 135(11):1578-90. PubMed ID: 15622663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable antipyretic effect of SC-58236, a selective cyclooxygenase (COX)-2 inhibitor, in rats.
    Akarsu ES; Mamuk S; Arat S
    Adv Exp Med Biol; 2003; 525():137-40. PubMed ID: 12751753
    [No Abstract]   [Full Text] [Related]  

  • 15. Third International Meeting on Cyclooxygenase-2--basic research and therapeutic use, Regensburg, Germany, June 7-8, 2002.
    Krämer BK
    Nephrol Dial Transplant; 2003 Mar; 18(3):477-8. PubMed ID: 12584266
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of intravenous parecoxib for the relief of acute post-surgical pain.
    Jain KK
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2717-23. PubMed ID: 11060833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second selective COX-2 inhibitor receives marketing approval.
    Miller JL
    Am J Health Syst Pharm; 1999 Jul; 56(13):1294. PubMed ID: 10683121
    [No Abstract]   [Full Text] [Related]  

  • 18. Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine.
    Li J; DeMello KM; Cheng H; Sakya SM; Bronk BS; Rafka RJ; Jaynes BH; Ziegler CB; Kilroy C; Mann DW; Nimz EL; Lynch MP; Haven ML; Kolosko NL; Minich ML; Li C; Dutra JK; Rast B; Crosson RM; Morton BJ; Kirk GW; Callaghan KM; Koss DA; Shavnya A; Lund LA; Seibel SB; Petras CF; Silvia A
    Bioorg Med Chem Lett; 2004 Jan; 14(1):95-8. PubMed ID: 14684306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial.
    Swan SK; Rudy DW; Lasseter KC; Ryan CF; Buechel KL; Lambrecht LJ; Pinto MB; Dilzer SC; Obrda O; Sundblad KJ; Gumbs CP; Ebel DL; Quan H; Larson PJ; Schwartz JI; Musliner TA; Gertz BJ; Brater DC; Yao SL
    Ann Intern Med; 2000 Jul; 133(1):1-9. PubMed ID: 10877734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific COX-2 inhibitors. Also effective in arthritis?].
    Einecke D
    MMW Fortschr Med; 2000 Jan; 142(3):10. PubMed ID: 10726454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.